RETRACTION: MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ ERK signaling pathways (Retraction of Vol 38, art no 494, 2019)

被引:0
|
作者
Zhang, Ruitao [1 ]
Shi, Huirong [1 ]
Ren, Fang [1 ]
Feng, Wei [1 ]
Cao, Yuan [1 ]
Li, Gailing [1 ]
Liu, Zheying [1 ]
Ji, Pengcheng [1 ]
Zhang, Minghui [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Gynecol, 1 East Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
D O I
10.1186/s13046-024-02978-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways
    Yue, Shi-Jun
    Zhang, Peng-Xuan
    Zhu, Yue
    Li, Nian-Guang
    Chen, Yan-Yan
    Li, Jia-Jia
    Zhang, Sai
    Jin, Ru-Yi
    Yan, Hao
    Shi, Xu-Qin
    Tang, Yu-Ping
    Duan, Jin-Ao
    MOLECULES, 2019, 24 (11):
  • [42] RETRACTION: BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway (Retraction of Vol 10, art no 237, 2019)
    Feng, Peng-Cheng
    Ke, Xing-Fei
    Kuang, Hui-Lan
    Pan, Li-Li
    Ye, Qiang
    Wu, Jian-Bing
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [43] RETRACTION: G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway (Retraction of Vol 140, art no 103129, 2020)
    Qiao, Hai-Feng
    Liu, Ying-Lei
    You, Jun
    Zheng, Yan-Li
    Chen, Li-Ping
    Lu, Xiao-Yan
    Du, Lei
    Shan, Feng
    Liu, Man-Hua
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 150
  • [44] RETRACTION: Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells (Retraction of Vol 38, art no 237, 2019)
    Wu, Dong-Mei
    Zheng, Zi-Hui
    Zhang, Ying-Bo
    Fan, Shao-Hua
    Zhang, Zi-Feng
    Wang, Yong-Jian
    Zheng, Yuan-Lin
    Lu, Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [45] RETRACTION: Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like (Retraction of Vol 20, art no 321, 2020)
    Cheng, Shaoqiang
    Xia, Bingshu
    Li, Hongbin
    Li, Yuying
    Lv, Xinxin
    Zhang, Yue
    Huang, Yuanxi
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [46] Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT
    Yan-yan Zhao
    Jing Jia
    Jing-jing Zhang
    Yan-ping Xun
    Shu-jun Xie
    Jia-feng Liang
    Hong-gang Guo
    Jia-zhen Zhu
    Sheng-lin Ma
    Shi-rong Zhang
    Acta Pharmacologica Sinica, 2021, 42 : 1288 - 1297
  • [47] Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT
    Zhao, Yan-yan
    Jia, Jing
    Zhang, Jing-jing
    Xun, Yan-ping
    Xie, Shu-jun
    Liang, Jia-feng
    Guo, Hong-gang
    Zhu, Jia-zhen
    Ma, Sheng-lin
    Zhang, Shi-rong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) : 1288 - 1297
  • [49] RETRACTION: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo (b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways (Retraction of Vol 8, art no E66246, 2013)
    Saxena, R.
    Chandra, V
    Manohar, M.
    Hajela, K.
    Debnath, U.
    Prabhakar, Y. S.
    PLOS ONE, 2020, 15 (03):
  • [50] Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells (vol 38, 240, 2019)
    Wang, Qun
    Lu, Weijun
    Yin, Tao
    Lu, Li
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)